Utama › Atrofi Geografik › Massachusetts
Kajian klinikal Atrofi Geografik di Massachusetts
7 kajian untuk Atrofi Geografik sedang mencari peserta di lokasi di Massachusetts.
Bandar di Massachusetts
Teks kajian rasmi (Bahasa Inggeris)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Ophthalmic Consultants of Boston, Boston
Mengambil pesertaFasa 2/3
Umur 60 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Ophthalmic Consultants of Boston, Waltham
Mengambil pesertaFasa 2
Umur 60 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Massachusetts Eye And Ear Infirmary, Boston
- Opthalmic Consultants of Boston, Boston
- New England Retina Consultants, PC, Springfield
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 50 hingga 85 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Research Institute at New England Retina Consultants, Springfield
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Ophthalmic Consultants of Boston, Boston
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT03178149Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Ophthalmic Consultants of Boston, East Weymouth
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07230834Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Tallman Eye Associates, Lawrence
Mengambil peserta
Umur 65 ke atas · Semua jantina · Dikemas kini 3 Dis 2024 · NCT05438732Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.